SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-005938
Filing Date
2017-05-30
Accepted
2017-05-30 08:00:33
Documents
4
Period of Report
2017-05-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k053017_biondvaxpharma.htm 6-K 19613
2 PRESS RELEASE, DATED MAY 30, 2017 f6k053017ex99i_biondvaxphar.htm EX-99.1 81428
3 BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDE f6k053017ex99ii_biondvaxphar.htm EX-99.2 227334
4 GRAPHIC ex99i_001.jpg GRAPHIC 29137
  Complete submission text file 0001213900-17-005938.txt   369620
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 17875640
SIC: 2836 Biological Products, (No Diagnostic Substances)